Literature DB >> 16838132

Mutational analysis of human BLyS in patients with common variable immunodeficiency.

Claretta Gioia Losi1, Ulrich Salzer, Roberta Gatta, Vassilios Lougaris, Gemma Cattaneo, Antonella Meini, Annarosa Soresina, Bodo Grimbacher, Alessandro Plebani.   

Abstract

BLyS, a TNF family member, is crucial for B cell proliferation and differentiation by acting through its three receptors, TACI, BCMA and BAFF-R. The knock out model for BLyS is characterized by an immunological phenotype reminiscent of the human phenotype of common variable immunodeficiency (CVID). CVID is characterized by a defective B cell compartment, evidencing the putative importance of BLyS in its pathogenesis. On the contrary, the transgenic model for BLys is characterized by autoimmune manifestations, underlying its role in B cell regulation. In fact, mutations in TACI, one of the three BLyS receptors, are associated with CVID. Based on these facts, we hypothesized that BLyS could be a candidate gene for CVID. We screened 78 patients with CVID using DHPLC and direct sequencing: No disease causing mutations were identified. A novel heterozygous single nucleotide polymorphism (SNP) was found in exon 1 of one individual, however this SNP (G189A) does not lead to an amino acid substitution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16838132     DOI: 10.1007/s10875-006-9026-2

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  17 in total

1.  Common variable immunodeficiency: clinical and immunological features of 248 patients.

Authors:  C Cunningham-Rundles; C Bodian
Journal:  Clin Immunol       Date:  1999-07       Impact factor: 3.969

Review 2.  Tackling the heterogeneity of CVID.

Authors:  Sigune Goldacker; Klaus Warnatz
Journal:  Curr Opin Allergy Clin Immunol       Date:  2005-12

3.  BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator.

Authors:  P A Moore; O Belvedere; A Orr; K Pieri; D W LaFleur; P Feng; D Soppet; M Charters; R Gentz; D Parmelee; Y Li; O Galperina; J Giri; V Roschke; B Nardelli; J Carrell; S Sosnovtseva; W Greenfield; S M Ruben; H S Olsen; J Fikes; D M Hilbert
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

4.  TALL-1 is a novel member of the TNF family that is down-regulated by mitogens.

Authors:  H B Shu; W H Hu; H Johnson
Journal:  J Leukoc Biol       Date:  1999-05       Impact factor: 4.962

5.  Characterization of a new member of the TNF family expressed on antigen presenting cells.

Authors:  C Tribouley; M Wallroth; V Chan; X Paliard; E Fang; G Lamson; D Pot; J Escobedo; L T Williams
Journal:  Biol Chem       Date:  1999-12       Impact factor: 3.915

6.  Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-kappaB, and c-Jun NH2-terminal kinase.

Authors:  A Mukhopadhyay; J Ni; Y Zhai; G L Yu; B B Aggarwal
Journal:  J Biol Chem       Date:  1999-06-04       Impact factor: 5.157

7.  Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease.

Authors:  Klaus Warnatz; Axel Denz; Ruth Dräger; Moritz Braun; Christoph Groth; Guido Wolff-Vorbeck; Hermann Eibel; Michael Schlesier; Hans Hartmut Peter
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

8.  B lymphocytes from individuals with common variable immunodeficiency respond to B lymphocyte stimulator (BLyS protein) in vitro.

Authors:  Donn M Stewart; Michael J McAvoy; David M Hilbert; David L Nelson
Journal:  Clin Immunol       Date:  2003-11       Impact factor: 3.969

9.  Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations.

Authors:  F Mackay; S A Woodcock; P Lawton; C Ambrose; M Baetscher; P Schneider; J Tschopp; J L Browning
Journal:  J Exp Med       Date:  1999-12-06       Impact factor: 14.307

10.  BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth.

Authors:  P Schneider; F MacKay; V Steiner; K Hofmann; J L Bodmer; N Holler; C Ambrose; P Lawton; S Bixler; H Acha-Orbea; D Valmori; P Romero; C Werner-Favre; R H Zubler; J L Browning; J Tschopp
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  4 in total

Review 1.  Cytokines in common variable immunodeficiency as signs of immune dysregulation and potential therapeutic targets - a review of the current knowledge.

Authors:  Farnaz Najmi Varzaneh; Bärbel Keller; Susanne Unger; Asghar Aghamohammadi; Klaus Warnatz; Nima Rezaei
Journal:  J Clin Immunol       Date:  2014-05-15       Impact factor: 8.317

2.  Screening of functional and positional candidate genes in families with common variable immunodeficiency.

Authors:  Ulrich Salzer; Carla Neumann; Jens Thiel; Cristina Woellner; Qiang Pan-Hammarström; Vassilis Lougaris; Tina Hagena; Johannes Jung; Jennifer Birmelin; Likun Du; Ayse Metin; David A Webster; Alessandro Plebani; Viviana Moschese; Lennart Hammarström; Alejandro A Schäffer; Bodo Grimbacher
Journal:  BMC Immunol       Date:  2008-02-07       Impact factor: 3.615

3.  Autoantibodies against BAFF, APRIL or IL21 - an alternative pathogenesis for antibody-deficiencies?

Authors:  Marian-Christopher Pott; Natalie Frede; Jennifer Wanders; Lennart Hammarström; Erik-Oliver Glocker; Cristina Glocker; Fariba Tahami; Bodo Grimbacher
Journal:  BMC Immunol       Date:  2017-06-26       Impact factor: 3.615

4.  Human BLyS facilitates engraftment of human PBL derived B cells in immunodeficient mice.

Authors:  Madelyn R Schmidt; Michael C Appel; Lisa J Giassi; Dale L Greiner; Leonard D Shultz; Robert T Woodland
Journal:  PLoS One       Date:  2008-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.